{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:57:32Z","timestamp":1793642252256,"version":"4.5.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T00:00:00Z","timestamp":1541116800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s10549-018-5029-y","type":"journal-article","created":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T10:26:14Z","timestamp":1541154374000},"page":"511-520","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Quantitative comparison of drug efficacy in treating hot flashes in patients with breast cancer"],"prefix":"10.1007","volume":"173","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6229-7781","authenticated-orcid":false,"given":"Ting","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghua","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingshan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lujin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,2]]},"reference":[{"key":"5029_CR1","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S0885-3924(02)00395-0","volume":"23","author":"PF Harris","year":"2002","unstructured":"Harris PF, Remington PL, Trentham-Dietz A, Allen CI, Newcomb PA (2002) Prevalence and treatment of menopausal symptoms among breast cancer survivors. J Pain Symptom Manag 23:501\u2013509","journal-title":"J Pain Symptom Manag"},{"key":"5029_CR2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S0140-6736(05)74803-0","volume":"365","author":"A Howell","year":"2005","unstructured":"Howell A, Cuzick J, Baum M, Buzdar A, Dowsett M, Forbes JF et al (2005) Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years\u2019 adjuvant treatment for breast cancer. Lancet 365:60\u201362","journal-title":"Lancet"},{"key":"5029_CR3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10549-007-9548-1","volume":"107","author":"D Cella","year":"2008","unstructured":"Cella D, Fallowfield LJ (2008) Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy. Breast Cancer Res Treat 107:167\u2013180","journal-title":"Breast Cancer Res Treat"},{"key":"5029_CR4","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10549-006-9193-0","volume":"99","author":"TL Lash","year":"2006","unstructured":"Lash TL, Fox MP, Westrup JL, Fink AK, Silliman RA (2006) Adherence to tamoxifen over the five-year course. Breast Cancer Res Treat 99:215\u2013220","journal-title":"Breast Cancer Res Treat"},{"key":"5029_CR5","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.breast.2016.02.013","volume":"27","author":"HY Chang","year":"2016","unstructured":"Chang HY, Jotwani AC, Lai YH, Jensen MP, Syrjala KL, Fann JR et al (2016) Hot flashes in breast cancer survivors: Frequency, severity and impact. Breast 27:116\u2013121","journal-title":"Breast"},{"key":"5029_CR6","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.clinthera.2007.02.006","volume":"29","author":"L Bordeleau","year":"2007","unstructured":"Bordeleau L, Pritchard K, Goodwin P, Loprinzi C (2007) Therapeutic options for the management of hot flashes in breast cancer survivors: an evidence-based review. Clin Ther 29:230\u2013241","journal-title":"Clin Ther"},{"key":"5029_CR7","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ctrv.2016.11.012","volume":"52","author":"RA Leon-Ferre","year":"2017","unstructured":"Leon-Ferre RA, Majithia N, Loprinzi CL (2017) Management of hot flashes in women with breast cancer receiving ovarian function suppression. Cancer Treat Rev 52:82\u201390","journal-title":"Cancer Treat Rev"},{"key":"5029_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1080\/09513590.2016.1247798","volume":"33","author":"MF Garrido Oyarzun","year":"2017","unstructured":"Garrido Oyarzun MF, Castelo-Branco C (2017) Use of hormone therapy for menopausal symptoms and quality of life in breast cancer survivors. Safe ethical? Gynecol Endocrinol 33:10\u201315","journal-title":"Gynecol Endocrinol"},{"key":"5029_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s10549-016-4002-x","volume":"160","author":"JB Hervik","year":"2016","unstructured":"Hervik JB, Stub T (2016) Adverse effects of non-hormonal pharmacological interventions in breast cancer survivors, suffering from hot flashes: a systematic review and meta-analysis. Breast Cancer Res Treat 160:223\u2013236","journal-title":"Breast Cancer Res Treat"},{"key":"5029_CR10","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s10549-016-3765-4","volume":"156","author":"C Johns","year":"2016","unstructured":"Johns C, Seav SM, Dominick SA, Gorman JR, Li H, Natarajan L et al (2016) Informing hot flash treatment decisions for breast cancer survivors: a systematic review of randomized trials comparing active interventions. Breast Cancer Res Treat 156:415\u2013426","journal-title":"Breast Cancer Res Treat"},{"key":"5029_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S1470-2045(00)00289-8","volume":"2","author":"CL Loprinzi","year":"2001","unstructured":"Loprinzi CL, Barton DL, Rhodes D (2001) Management of hot flashes in breast-cancer survivors. Lancet Oncol 2:199\u2013204","journal-title":"Lancet Oncol"},{"key":"5029_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/13697130500487224","volume":"9","author":"P Gupta","year":"2006","unstructured":"Gupta P, Sturdee DW, Palin SL, Majumder K, Fear R, Marshall T et al (2006) Menopausal symptoms in women treated for breast cancer: the prevalence and severity of symptoms and their perceived effects on quality of life. Climacteric 9:49\u201358","journal-title":"Climacteric"},{"key":"5029_CR13","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1002\/pon.793","volume":"13","author":"MS Hunter","year":"2004","unstructured":"Hunter MS, Grunfeld EA, Mittal S, Sikka P, Ramirez AJ, Fentiman I et al (2004) Menopausal symptoms in women with breast cancer: prevalence and treatment preferences. Psychooncology 13:769\u2013778","journal-title":"Psychooncology"},{"key":"5029_CR14","volume-title":"Guideline on clinical investigation of medicinal products for hormone replacement therapy of oestrogen deficiency symptoms in postmenopausal women","author":"CHMP E","year":"2005","unstructured":"CHMP E (2005) Guideline on clinical investigation of medicinal products for hormone replacement therapy of oestrogen deficiency symptoms in postmenopausal women. European Medicines Agency, London"},{"key":"5029_CR15","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s00228-016-2090-5","volume":"72","author":"L Li","year":"2016","unstructured":"Li L, Xu L, Wu J, Dong L, Zhao S, Zheng Q (2016) Comparative efficacy of nonhormonal drugs on menopausal hot flashes. Eur J Clin Pharmacol 72:1051\u20131058","journal-title":"Eur J Clin Pharmacol"},{"key":"5029_CR16","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1097\/GME.0000000000000858","volume":"24","author":"L Li","year":"2017","unstructured":"Li L, Xu L, Wu J, Dong L, Lv Y, Zheng Q (2017) Quantitative analysis of placebo response and factors associated with menopausal hot flashes. Menopause 24:932\u2013937","journal-title":"Menopause"},{"key":"5029_CR17","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1080\/0167482X.2017.1350163","volume":"38","author":"D Fenlon","year":"2017","unstructured":"Fenlon D, Morgan A, Khambaita P, Mistry P, Dunn J, Ah-See ML et al (2017) Management of hot flushes in UK breast cancer patients: clinician and patient perspectives. J Psychosom Obstetr Gynaecol 38:276\u2013283","journal-title":"J Psychosom Obstetr Gynaecol"},{"key":"5029_CR18","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1038\/bjc.2013.116","volume":"108","author":"B Makubate","year":"2013","unstructured":"Makubate B, Donnan PT, Dewar JA, Thompson AM, McCowan C (2013) Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality. Br J Cancer 108:1515\u20131524","journal-title":"Br J Cancer"},{"key":"5029_CR19","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1210\/jc.2017-01138","volume":"102","author":"RJ Santen","year":"2017","unstructured":"Santen RJ, Stuenkel CA, Davis SR, Pinkerton JV, Gompel A, Lumsden MA (2017) Managing menopausal symptoms and associated clinical issues in breast cancer survivors. J Clin Endocrinol Metab 102:3647\u20133661","journal-title":"J Clin Endocrinol Metab"},{"key":"5029_CR20","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1097\/gme.0b013e3181dbee1b","volume":"17","author":"H Joffe","year":"2010","unstructured":"Joffe H, Partridge A, Giobbie-Hurder A, Li X, Habin K, Goss P et al (2010) Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial. Menopause 17:908\u2013916","journal-title":"Menopause"},{"key":"5029_CR21","doi-asserted-by":"publisher","first-page":"6919","DOI":"10.1200\/JCO.2005.10.081","volume":"23","author":"V Stearns","year":"2005","unstructured":"Stearns V, Slack R, Greep N, Henry-Tilman R, Osborne M, Bunnell C et al (2005) Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial. J Clin Oncol 23:6919\u20136930","journal-title":"J Clin Oncol"},{"key":"5029_CR22","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.4067\/S0034-98872016001000013","volume":"144","author":"OM Irarrazaval","year":"2016","unstructured":"Irarrazaval OM, Gaete GL (2016) [Antidepressants agents in breast cancer patients using tamoxifen: review of basic and clinical evidence]. Revista medica de Chile 144:1326\u20131335","journal-title":"Revista medica de Chile"},{"key":"5029_CR23","doi-asserted-by":"publisher","first-page":"3862","DOI":"10.1200\/JCO.2010.33.1298","volume":"29","author":"AH Boekhout","year":"2011","unstructured":"Boekhout AH, Vincent AD, Dalesio OB, van den Bosch J, Foekema-Tons JH, Adriaansz S et al (2011) Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial. J Clin Oncol 29:3862\u20133868","journal-title":"J Clin Oncol"},{"key":"5029_CR24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S1470-2045(08)70341-3","volume":"10","author":"P Kenemans","year":"2009","unstructured":"Kenemans P, Bundred NJ, Foidart JM, Kubista E, von Schoultz B, Sismondi P et al (2009) Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial. Lancet Oncol 10:135\u2013146","journal-title":"Lancet Oncol"},{"key":"5029_CR25","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/gme.0b013e31818c91ca","volume":"16","author":"A Bardia","year":"2009","unstructured":"Bardia A, Novotny P, Sloan J, Barton D, Loprinzi C (2009) Efficacy of nonestrogenic hot flash therapies among women stratified by breast cancer history and tamoxifen use: a pooled analysis. Menopause 16:477\u2013483","journal-title":"Menopause"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-018-5029-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-018-5029-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-018-5029-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T20:31:57Z","timestamp":1572640317000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-018-5029-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,2]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["5029"],"URL":"https:\/\/doi.org\/10.1007\/s10549-018-5029-y","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,2]]},"assertion":[{"value":"28 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All the authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}